Safety and Immunogenicity of the ChadOx1 nCoV-19 (AZD1222) Vaccine in Children Aged 12-17 Years: A Preliminary Report of a Phase 2, Single-Blind, Randomised Controlled Trial (COV006)
SSRN Electronic Journal (2021) - Comments
doi: 10.2139/ssrn.3989844  issn: 1556-5068 

Grace Li, Federica Cappuccini, Natalie G. Marchevsky, Parvinder K. Aley, Robert Aley, Rachel Anslow, Sagida Bibi, Katrina Cathie, Elizabeth Clutterbuck, Rachel Cooper, Saul N. Faust, Shuo Feng, Paul T. Heath, Simon Kerridge, Alice Lelliott, Yama Mujadidi, Khuen Foong Ng, Sarah Rhead, Hannah Roberts, Hannah Robinson